by European Public Health Alliance | Mar 27, 2016 | Opinion
By Sascha Marschang, Policy Manager, EPHA The latest terrorist attacks in Europe, combined with big political question marks hanging over the UK, Turkey and elsewhere, are contributing to the general malaise felt by many Europeans – uncertainty and distress as a...
by European Public Health Alliance | Mar 2, 2016 | Opinion
In February, trade negotiators from the EU and the US met in Brussels for the twelfth round of negotiations on the Transatlantic Trade and Investment Partnership (TTIP) – behind closed doors. Among other things, they discussed an EU proposal on regulatory...
by European Public Health Alliance | Mar 2, 2016 | Opinion
In the wake of the ENVI Committee vote on 17 February, fifty medics, scientists and public health organisations (including the Royal College of Physicians and EPHA) signed a letter initiated by the Alliance to Save Our Antibiotics demanding a ban to the “routine,...
by European Public Health Alliance | Mar 2, 2016 | Opinion
by Yannis Natsis Policy Coordinator Universal access and affordable medicines, EPHA Since the start of the Juncker Commission, we are witnessing an awkward new reality. There is no major new health-related legislation heading for the European Parliament, and nothing... by European Public Health Alliance | Mar 2, 2016 | Opinion
In February, trade negotiators from the EU and the US met in Brussels for the twelfth round of negotiations on the Transatlantic Trade and Investment Partnership (TTIP) – behind closed doors. Amongst other things, they discussed an EU proposal on regulatory...
by European Public Health Alliance | Feb 1, 2016 | Opinion
The Dutch Presidency appears to be keeping its cards close to its chest as far as pharmaceuticals and public health are concerned. So far, they seem to have been purposefully ambiguous about their intentions and have not put forward any concrete proposals on the...
